Scribe Therapeutics, Inc. (SCTX)
19.40
-1.27
(-6.14%)
USD |
NASDAQ |
Oct 13, 09:43
Scribe Therapeutics Gross Profit Margin (Quarterly) : 59.07% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 59.07% |
| March 31, 2026 | 65.38% |
| Date | Value |
|---|---|
| June 30, 2025 | 82.93% |
| March 31, 2025 | 94.97% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 96.13% |
| Twist Bioscience Corp. | 52.76% |
| Veracyte, Inc. | 71.93% |
| Cypherpunk Technologies, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 90.81% |
Gross Profit Margin (Quarterly) Related Metrics
| Profit Margin (Quarterly) | -337.7% |
| Operating Margin (Quarterly) | -489.8% |